MediMix aims to bring high value medical information to Belgian healthcare professionals via multiple channels. Our team covers congresses and symposia all over the world, particularly in the oncology domain. In collaboration with Belgian and international experts, we bring the newest data to Belgian physicians.
Prof Dr Mireille Fontsa Langouo provides some key insights into treating acral
lentiginous melanoma (ALM). She also emphasises the emerging role of
biomarkers in predicting patient response and
Dr Bart Appeltans, an oncologic surgeon at the Jessa Hospital in Hasselt, Belgium, discussed some interesting novelties in melanoma surgery.
Dr Vincent Geldhof discussed some interesting novelties in melanoma treatment. These promising developments focused on novel immunotherapies, treatment strategies for BRAF-mutated melanoma, and updated insights into therapy-related toxicity.
During EADO 2025, Dr Celine Jacobs, discussed three studies presented during the session on squamous cell carcinoma and rare tumours.
In this video, Prof Dr Mariana Brandão shares her key take-aways from the second proffered paper session of the 2025 European Lung Cancer Conference (ELCC).
In this video, Prof Dr Thierry Berghmans provides a summary of the second mini-oral session during the 2025 European Lung Cancer Conference (ELCC).
In this video, Prof Dr Lore Decoster provides a brief summary of the first mini-oral session of the 2025 European Lung Cancer Conference (ELCC).
In this video, Prof Em Johan Vansteenkiste discusses the key take-aways from the first proferred paper session of ELCC 2025. The most anticipated presentation at ELCC 2025 featured the overall
MediMix is introducing “What’s New Doc?” – a weekly update on the latest research in different cancer domains.
Belgian experts provide you with detailed information on the latest data and offer you fresh insights into treatment and research.
